
Advent to acquire a significant minority stake in Felix Pharmaceuticals, Ireland
Press Release – Mumbai, 9th June 2025 – Advent, a leading global private equity investor, today announced that funds managed by Advent have signed a definitive agreement to invest USD $175 million via primary and secondary for a significant minority stake in Dublin headquartered Felix Pharmaceuticals Pvt Ltd (“Felix”), a leading global Gx animal pharma player. Felix Pharma is one of the fastest growing developers and manufacturer … Continue reading Advent to acquire a significant minority stake in Felix Pharmaceuticals, Ireland